Showing results (271-280 of 282) with videos related to
Sort By:
Pageof 29
Klinische Padiatrie|June 4, 2004
The concept of the GPOH-HD 2003 therapy study for pediatric Hodgkin's disease: evolution in the tradition of the DAL/GPOH studiesD Körholz, A Claviez, D Hasenclever, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 11, 2019
Failure to detect an association between self-reported traumatic brain injury and Alzheimer's disease neuropathology and dementiaMichael A Sugarman, Ann C McKee, Thor D Stein, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 6, 2001
Allogeneic and autologous stem-cell transplantation in advanced Ewing tumors. An update after long-term follow-up from two centers of the European Intergroup study EICESS. Stem-Cell Transplant Programs at Düsseldorf University Medical Center, Germany and St. Anna Kinderspital, Vienna, AustriaS Burdach, B van Kaick, H J Laws, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 3, 2010
Carrier testing for spinal muscular atrophyJonathan M Gitlin, Kenneth Fischbeck, Thomas O Crawford, et al.Neurobiology of Aging|June 26, 2020
A longitudinal examination of plasma neurofilament light and total tau for the clinical detection and monitoring of Alzheimer's diseaseMichael A Sugarman, Henrik Zetterberg, Kaj Blennow, et al.International Journal of Cancer|July 13, 2002
Prevalence of human papillomavirus in cervical cancer: a multicenter study in ChinaKeith W K Lo, Y F Wong, May K M Chan, et al.Brain : a Journal of Neurology|May 13, 2022
Ante-mortem plasma phosphorylated tau (181) predicts Alzheimer's disease neuropathology and regional tau at autopsyMadeline S Morrison, Hugo J Aparicio, Kaj Blennow, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 2, 2021
Plasma p-tau181 shows stronger network association to Alzheimer's disease dementia than neurofilament light and total tauBrandon Frank, Madeline Ally, Bailee Brekke, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|October 27, 2023
Cross-sectional and longitudinal evaluation of plasma glial fibrillary acidic protein to detect and predict clinical syndromes of Alzheimer's diseaseMadeline Ally, Michael A Sugarman, Henrik Zetterberg, et al.Journal of Alzheimer'S Disease : JAD|March 28, 2025
Sex differences on tau, astrocytic, and neurodegenerative plasma biomarkersJacob Labonte, Michael A Sugarman, Erika Pettway, et al.Pageof 29